In breast cancer, IFN‐γ‐induced CAFs upregulate elastin microfibrillar interface protein 1 (EMILIN1), an inhibitor of TGF‐β activity, to enhance CD8+ T cell infiltration. Here, TGFB1 is linked to breast cancer.